Germany· DE-A57-52f7fcb7fad71538
Trazodon Pharmaclan
A trazodone product containing trazodone hydrochloride, registered in Germany by Pharmaclan S.R.O.. The same ATC class is registered in 15 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Trazodone is registered in 15 of 19 countries.
Countries holding a registration under ATC N06AX05 (trazodone), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Trazodone · ATC N06AX05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of trazodone costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.36 in Spain to $2.99 in Switzerland — a ×8.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trazodone · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.99
- IT Italy$1.02
- ES Spain$0.36
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Trazodone Hydrochloride
- Manufacturer
- Pharmaclan S.R.O.
- Country
- Germany (DE)
- ATC code
- N06AX05
- ATC class
- Trazodone
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
394 interactions on record for trazodone.
Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trazodone · interactions on record
394 records
- 54 severe
- 216 moderate
- 7 minor
- 84 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AX05
Trazodone, as other registers publish it.
- CanadaAG-TRAZODONEANGITA PHARMA INC.
- CanadaAG-TRAZODONEANGITA PHARMA INC.
- CanadaAG-TRAZODONEANGITA PHARMA INC.
- NorwayApo-TrazodoneApotex
- CanadaAPO-TRAZODONE D TABLETS 150MGAPOTEX INC
- CanadaAPO-TRAZODONE TABLETS 100MGAPOTEX INC
- CanadaAPO-TRAZODONE TABLETS 50MGAPOTEX INC
- FinlandAzonaOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2ec97eb6-2695-43b4-8da6-f7bb123076f3 GET /v1/drugs/2ec97eb6-2695-43b4-8da6-f7bb123076f3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Trazodone Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about trazodone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.